Xvivo Perfusion Q3’20: First impression

Research Note

2020-10-23

08:11

Redeyes first impressions on the Q3 results. Sales came in slightly higher than we expected at SEK 42.7m vs. our SEK 40.2m. The gross margin was a tad higher than expected at 78% vs. our expectation of 76.5%. There are relatively small deviations considering the low visibility at present.

MH

Mats Hyttinge

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.